Recent Advances in Interstitial Lung Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 20 May 2024 | Viewed by 108
Special Issue Editor
Special Issue Information
Dear Colleagues,
A complete score, including all principal variables used to stratify idiopathic pulmonary fibrosis (IPF) patients, is currently lacking. Moreover, there is no standard definition of disease progression and no decline rate has been formally accepted in patients with IPF. At present, scores are only limited to a comparison between IPF and one or two variables (such as pulmonary function tests, high-resolution computed tomography, or acute exacerbation) which are evaluated singularly. In addition, pulmonary hypertension is underestimated or not considered in IPF data analysis.
According to the literature, we suggest dividing all risk predictors into:
- probable predictors;
- potential predictors.
On the basis of the severity of each risk factor on IPF outcome, we also aim to:
- define the worse predictive risk factors in IPF;
- propose an accurate and complete predictor risk score of poor outcome with all principal variables;
- identify a standard definition of disease progression;
- enable clinicians to better evaluate eligibility criteria for anti-fibrotic therapy or lung transplantation strategies in clinical practice.
Prof. Dr. Roberto Carbone
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- idiopathic pulmonary fibrosis
- disease progression definition
- severity score predictors
